MedTrace Logo

Gait, cOgnitiOn & Decline (GOOD)

NCT02350270 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2800

Last updated 2015-01-29

No results posted yet for this study

Summary

The main objective of the GOOD initiative was to determine which spatio-temporal gait parameters and/or combination(s) of spatio-temporal gait parameters best differentiate between cognitively healthy individuals (CHI), patients with mild cognitive impairment (MCI) and those with mild and moderate dementia.

Conditions

Interventions

OTHER

gait and cognitive testing

Sponsors & Collaborators

  • Biomathics

    collaborator UNKNOWN

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Olivier Beauchet, MD, PhD · Angers University Hospital

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-06-30
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02350270 on ClinicalTrials.gov